Business Context and Reporting Period
This Form 6-K filing by Therapix Biosciences Ltd. (not Scisparc Ltd.) covers the month of December 2020. The report serves as a notification regarding the format of the Company's Special General Meeting of Shareholders scheduled for January 6, 2021.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural announcement and does not contain financial statements or performance data.
Material Changes
There are no financial material changes reported. The primary operational change is the decision to hold the Special General Meeting of Shareholders virtually via Zoom videoconference rather than in person, in accordance with rules adopted by Israeli authorities.
Guidance, Outlook, and Risks
Management commentary is limited to logistical instructions for shareholders. Shareholders wishing to participate must register by emailing a notice of attendance to the Chief Financial Officer, Mr. Oz Adler, by 7:00 a.m. Eastern Time on January 6, 2021. No financial guidance, outlook, or specific risk factors are disclosed in this text.
Key Facts for Investor Verification
- The Special General Meeting will be held virtually on January 6, 2021, at 8:00 a.m. Eastern Time.
- Shareholders must register via email to oz@therapixbio.com by the specified deadline to receive the Zoom link.
- This filing incorporates by reference into the Company's registration statements on Form F-3 and Form S-8.
- The registrant is Therapix Biosciences Ltd., based in Ramat Gan, Israel.